INOVIQ in the News

    Fundie Merchant Group picks four biotech stocks that could rip as sector hits rude health again  
    David Williams to join INOVIQ board  
    ASX Small and Mid-Cap Conference September 2023 | INOVIQ Ltd (ASX: IIQ)  
    Stocks of the Hour: Empire Energy, INOVIQ, Southern Cross Gold  
    INOVIQ strives to lift the bar on breast and ovarian cancer diagnostics  
    INOVIQ's breast cancer test outperforms leading approved test  
    The Market Herald: INOVIQ (ASX:IIQ) teams up with Promega in global marketing agreement  
    Ausbiz: Opportunities in small cap | INOVIQ - Promega collaboration  
    Stockhead: Key deal signed by INOVIQ  
    Channel 7’s Flashpoint featured INOVIQ in its ASX - Runners of the Week  
    Breakthrough breast cancer test delivers hope in clinical study  
    ASX Health stocks: INOVIQ soars 44pc on clinical data for breast cancer test  
    Stocks of the Hour: INOVIQ, Forrestania, Lincoln, Tamboran  
    INOVIQ CSO Professor Greg Rice receives placentology scientific award  
    Sectors mixed as ASX edges 0.35% higher  
    Stocks of the Hour: Tennant Minerals, Latin Resources, INOVIQ  
    Passing of Professor Allan Cripps AO  
    INOVIQ presents at the MST Access Diagnostics Forum  
    Stocks of the Hour: Kingwest Resources, Doctor Care Anywhere, INOVIQ  
    China's lockdown rampage causes lower start to ASX  
    Lithium stocks falling, Critical Minerals Summit commencing: ASX up 0.29% at noon  
    The Australian: Lots of milestones expected from INOVIQ in 2023 as it aims to commercialise cancer diagnostics products in the US  
    The Market Herald: INOVIQ signs agreement with Nicoya Lifesciences to develop SubB2M-based test  
    Financials keeping the local market in the green: ASX up 0.51% at noon  
    Stockhead Health & Biotech Investment Guide  
    INOVIQ carving itself healthy share of multi-billion dollar medical diagnostics market  
    INOVIQ (ASX:IIQ) discusses US milestones  
    INOVIQ study validates the use of SubB2M as an aid in diagnosing malignant melanoma  
    Energy, miners and BNPL shares lead the way: Aus shares close 0.3% higher  
    ASX in a holding pattern: Aus shares 0.2% higher at noon  
    INOVIQ expands US footprint with new sales team  
    Energy and miners drag ASX lower, down 0.6% over the week  
    INOVIQ (ASX:IIQ) granted SubB2M US patent for diagnostic applications  
    Inoviq expands collaboration with UQ to develop exosome-based ovarian cancer screening test  
    INOVIQ wants to beat cancer to the punch with world-first diagnostic solutions  
    Bard1 Awarded Biomedical Translation Bridge Funding to Develop Breast Cancer Tests  
    BARD1 Life Sciences (ASX:BD1) Presentation, FNN Online Investor Event, October 2021  
    INOVIQ reveals its SubB2M technology can detect all stages of breast cancer from a blood sample, 100% specificity and 95% sensitivity.  
    INOVIQ share price doubles following positive announcement on ovarian cancer detection technology.  
    Media release: The Australian Government is backing several Australian research projects aimed at finding breakthrough treatments, diagnostics and a vaccine in the fight against COVID-19.  
    AusBiotech: Government announces support for COVID-19 research projects  
    INOVIQ Life Sciences (ASX:BD1) receives European patent validation for cancer tests  
    INOVIQ Limited was represented at the AACR Annual Meeting 2020 by CSO Dr Irmgard Irminger-Finger who gave an invited oral presentation on 24 April 2020.  
    Proactive Investors covers INOVIQ breast cancer test announcement today INOVIQ develops world’s first blood test for early detection of breast cancer  
    Article published by SmallCaps today INOVIQ develops world first blood test for breast cancer detection  
    Article published by StocksDigital in nextBIOTECH Top Results: INOVIQ Continues to Boost its Ovarian Cancer Detection Studies  
    Article published by finfeed INOVIQ inks critical deal to develop autoantibody test  
    Interview of INOVIQ CEO Dr Leearne Hinch by Proactive Investors INOVIQ approaching “important milestone” on path to commercialisation  
    Article published by Proactive Investors INOVIQ signs agreement to develop custom research assay  
    INOVIQ announces positive results from ovarian cancer test  
    Article published by SMALL CAPS on INOVIQ’s Ovarian Cancer Detection Study  
    Interview of INOVIQ LSL Executive Director and CSO Dr Irmgard Irminger-Finger by Startwerk “BARD1AG SA: The real fight against lung cancer”